deltatrials
Unknown OBSERVATIONAL NCT02126189

The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study

An Epidemiological Study of Mucosal Squamous Cell Carcinomas of the Head and Neck

Sponsor: Princess Alexandra Hospital, Brisbane, Australia

Updated 11 times since 2017 Last updated: Apr 20, 2015 Started: Nov 30, 2013 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02126189, this observational or N/A phase trial focuses on Head and Neck Squamous Cell Carcinoma and Human Papillomavirus and remains ongoing. Sponsored by Princess Alexandra Hospital, Brisbane, Australia, it has been updated 11 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Study Description(click to expand)

Data is collected using a simple four-page paper-based questionnaire. Information to be collected include age, sex, height and weight (at age 20, current age, and heaviest ever), history of cancer (own and partner). Questions about recreational physical activity, smoking history and alcohol consumption, acid reflux, heartburn, denture use and tonsillectomy, frequency of use of paracetamol, antihistamine and NSAIDS. The questionnaires also ask participants some detailed questions about sexual behaviour and history if they are comfortable to give this information.

Data is collected using a simple four-page paper-based questionnaire. Information to be collected include age, sex, height and weight (at age 20, current age, and heaviest ever), history of cancer (own and partner). Questions about recreational physical activity, smoking history and alcohol consumption, acid reflux, heartburn, denture use and tonsillectomy, frequency of use of paracetamol, antihistamine and NSAIDS.

The questionnaires also ask participants some detailed questions about sexual behaviour and history if they are comfortable to give this information.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshotRecruiting~May 2017 – ~Aug 2017 · 3 months · monthly snapshotUnknown Status~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotUnknown Status~Apr 2018 – ~May 2018 · 30 days · monthly snapshotUnknown Status~May 2018 – ~Jun 2018 · 31 days · monthly snapshotUnknown Status~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotUnknown Status~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotUnknown Status~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotUnknown Status~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 19 months · monthly snapshotUnknown

Change History

11 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Dec 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Jan 2021 — Dec 2021 [monthly]

    Unknown Status

  5. Nov 2020 — Jan 2021 [monthly]

    Unknown Status

Show 6 earlier versions
  1. Jun 2018 — Nov 2020 [monthly]

    Unknown Status

  2. May 2018 — Jun 2018 [monthly]

    Unknown Status

  3. Apr 2018 — May 2018 [monthly]

    Unknown Status

    Phase: NANone

  4. Aug 2017 — Apr 2018 [monthly]

    Unknown Status NA

  5. May 2017 — Aug 2017 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

  6. Jan 2017 — May 2017 [monthly]

    Recruiting NA

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Princess Alexandra Hospital, Brisbane, Australia
  • QIMR Berghofer Medical Research Institute
  • Queensland Centre of Excellence for Head and Neck Cancer
  • The University of Queensland
  • Translational Research Institute, Brisbane, Australia
Data source: Queensland Centre of Excellence for Head and Neck Cancer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations